A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Investigating the Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery
Latest Information Update: 17 May 2022
At a glance
- Drugs BGE 117 (Primary) ; Ferrous sulfate
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors BioAge Labs
- 29 Apr 2022 Planned primary completion date changed from 1 Mar 2023 to 1 Apr 2023.
- 29 Apr 2022 Planned initiation date changed from 1 Dec 2021 to 1 Apr 2022.
- 29 Apr 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.